Appendix F
Agendas of Stakeholder Meetings Held by the Committee on Review of Priorities in the National Vaccine Plan (July 2008-June 2009)
FIRST NATIONAL STAKEHOLDER MEETING VACCINE SUPPLY AND USE
Thursday, July 24, 2008
University of Chicago Gleacher Center, Room 300
Chicago, Illinois
8:15 – 8:30 am |
Welcome and Committee Introductions Claire V. Broome Institute of Medicine (IOM) Committee Chair |
8:30 – 9:45 am |
Childhood immunization schedule Melinda Wharton Deputy Director National Center for Immunizations and Respiratory Diseases (NCIRD) Centers for Disease Control and Prevention (CDC) |
|
Alternative venues for immunization (adolescent and adult) Gina Mootrey Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention |
|
Incentives and requirements (across the lifespan) Lance Rodewald Director Immunization Services Division National Center for Immunization and Respiratory Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention |
|
Surveillance and monitoring Anne Schuchat RADM, U.S. Public Health Service (PHS) Director, National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention |
9:45 – 10:00 am |
Committee questions |
10:00 – 10:45 am |
Panel: Surveillance and information systems Mike Garcia Vice President and Chief Operations Officer Scientific Technologies Corporation |
|
Christine Hahn Idaho State Epidemiologist Department of Health and Welfare |
|
Discussant: Emily Peterson Coordinator, Immunization Information Systems Minnesota Department of Health |
10:45 – 11:15 am |
Committee questions and discussion |
11:15 – 11:45 am |
Achieving better use of vaccines Gregory A. Poland Director Vaccine Research Group Mayo Clinic |
11:45 am – 12:00 pm |
Committee questions and discussion |
12:00 – 1:00 pm |
Lunch |
1:00 – 2:00 pm |
Panel: Access to immunization services Jeffrey Duchin Chief, Communicable Disease Control Epidemiology and Immunization Section Public Health—Seattle & King County |
|
Mitchel Rothholtz Chief of Staff American Pharmacists Association |
|
Carl Toren Medical Director Chicago Family Health Center |
|
Discussants: Lyle J. Fagnan Director, Oregon Rural Practice-Based Research Network Associate Professor of Family Medicine Oregon Health and Science University Representative, American Academy of Family Practice |
|
Cheryl A. Peterson Senior Policy Fellow Department of Nursing Practice and Policy American Nurses Association |
2:00 – 2:30 pm |
Committee questions and discussion |
2:30 – 3:10 pm |
Vaccine finance: Overview of stakeholder input and NVAC working group draft white paper Walter Orenstein National Vaccine Advisory Committee (NVAC) Vaccine Finance Working Group Associate Director, Emory Vaccine Center Director, Emory Program for Vaccine Policy and Development Emory University |
|
Discussants: Ann Clemency Kohler Executive Director National Association of State Medicaid Directors |
|
Alan Rosenberg Vice President Wellpoint, Inc. Representative, America’s Health Insurance Plans |
3:10 – 3:30 pm |
Committee questions and discussion |
3:30 – 3:45 pm |
Break |
3:45 – 4:15 pm |
Panel: Provider knowledge and practice George Isham Chief Health Officer Health Partners |
|
Allison Kempe Professor of Pediatrics Director, Primary Care Research Fellowship Director, Children’s Outcomes Research Program University of Colorado at Denver Health Sciences Center |
|
Julie Morita Medical Director Immunization Program Chicago Department of Public Health |
|
Discussants: Lyle J. Fagnan Director, Oregon Rural Practice-Based Research Network Associate Professor of Family Medicine Oregon Health and Science University Representative, American Academy of Family Practice |
|
Wayne Hachey Director, Preventive Medicine and Surveillance Office of the Assistant Secretary of Defense (Health Affairs) Force Health Protection and Readiness Department of Defense |
4:15 – 4:45 pm |
Committee questions and discussion |
4:45 – 5:45 pm |
Panel: Vaccine supply Norman W. Baylor Office of Vaccines Research and Review Center for Biologics Evaluation and Research (CBER) Food and Drug Administration (FDA) |
|
Laurel Wood Manager Immunization Program Alaska Department of Health and Social Services Chair Association of Immunization Managers |
|
Discussants: Marguerite D. Baxter Vice President and Head, Global Public Affairs Novartis Vaccines and Diagnostics, Inc. |
|
Isabelle Claxton Director Public Policy and Advocacy GSK Vaccines |
|
John D. Grabenstein Senior Director, Adult Vaccine Medical Affairs Merck Vaccines & Infectious Diseases |
|
Gregory S. Wallace Chief, Vaccine Supply & Assurance Branch Immunization Services Division National Center for Immunization & Respiratory Diseases Centers for Disease Control and Prevention |
5:45 – 6:15 pm |
Committee questions and discussion |
6:15 – 6:30 pm |
Public comment |
SECOND NATIONAL STAKEHOLDER MEETING DEVELOPMENT OF NEW AND IMPROVED VACCINES
Monday, December 1, 2008
Huntington Room, Arnold and Mabel Beckman Center
100 Academy Drive
Irvine, California
Please note:
Panelist titles and affiliations are provided at the end of the agenda.
(*) denotes panelists who will give a formal presentation
(†) denotes panelists who contributed to the draft National Vaccine Plan
8:30 am |
Welcome and Committee Introductions Claire V. Broome Institute of Medicine (IOM) Committee Chair |
8:45 – 10:15 am |
Panel 1: Encouraging scientific innovation (new vaccines, better vaccines) Moderator: Milagritos Tapia (IOM committee member) |
|
Panelists: Philip Dormitzer (Novartis) Kathryn Edwards (Vanderbilt University) Emil Gotschlich (Rockefeller University) Harry Greenberg (Stanford University) Diane Griffin (Johns Hopkins University) Ed Mocarski* (MedImmune) Barbara Mulach†(National Institutes of Health [NIH]/National Institute of Allergy and Infectious Diseases [NIAID]) Stanley Plotkin* (Sanofi) Robin Robinson†(HHS/BARDA) Rebecca Sheets†(NIH/NIAID) (via video) Justin Wright (BD Medical-Pharmaceutical Systems) |
10:15 – 10:30 am |
Break |
10:30 – 11:15 am |
Panel 1 continued |
11:15 am – 12:30 pm |
Panel 2: Financing vaccine research and development Moderator: Claire V. Broome (IOM Committee Chair) |
|
Panelists: Harry B. Greenberg (Stanford University) Karl D. Handelsman (CMEA Ventures) David C. Kaslow (Merck) Leighton Read* (Alloy Ventures) Jeffrey Ulmer (Novartis) |
12:30 – 1:30 pm |
Lunch |
1:30 – 3:00 pm |
Panel 3: Addressing public needs and priorities Moderator: Edgar Marcuse (IOM committee member) |
|
Panelists: Philip R. Dormitzer (Novartis) Kathryn Edwards (Vanderbilt University) David C. Kaslow (Merck) Edward Mocarski (MedImmune) |
|
Stanley A. Plotkin* (Sanofi) Robin Robinson†(HHS/BARDA) |
3:00 – 3:15 pm |
Break |
3:15 – 4:30 pm |
Panel 4: Regulatory and other issues in developing and licensing novel processes, new technologies, etc. Moderator: Arthur Reingold (IOM committee member) |
|
Panelists: Karl D. Handelsman (CMEA Ventures) David C. Kaslow (Merck) Karen Midthun (FDA/CBER) Leighton Read (Alloy Ventures) Rebecca Sheets†(NIH/NIAID) (via video) Jeffrey Ulmer (Novartis) |
4:30 – 5:30 pm |
Closing dialogue Moderator: Claire V. Broome (IOM committee chair) Question to all stakeholders at the meeting: What criteria would you use to determine what objectives should receive the greatest level of attention in the National Vaccine Plan? Final observations about the day’s discussions All panelists and audience members |
5:30 pm |
Adjourn |
PANELIST TITLES AND AFFILIATIONS
Philip Dormitzer
Senior Director and Senior Project Leader (viral vaccine research)
Novartis Vaccines and Diagnostics
Kathryn Edwards
Sarah Sell Professor of Pediatrics
Director, Division of Pediatric Clinical Research
Vanderbilt University School of Medicine
Emil Gotschlich
R. Gwin Follis-Chevron Professor
Laboratory of Bacterial Pathogenesis and Immunology
Rockefeller University
Harry B. Greenberg
Senior Associate Dean for Research and Training
Stanford University School of Medicine
Professor of Medicine (Gastroenterology & Hepatology) Microbiology and Immunology, and Staff Physician VA Palo Alto Health Care System
Diane Griffin
Professor
Alfred and Jill Sommer Professor and Chair in Molecular Microbiology and Immunology
Johns Hopkins Bloomberg School of Public Health
Karl D. Handelsman
Managing Director
CMEA Ventures
David C. Kaslow
Vice President, Infectious Diseases and Vaccines Franchise
Merck Research Laboratories
Karen Midthun
Deputy Director, Center for Biologics Evaluation and Research
Food and Drug Administration
Edward S. Mocarski, Jr.*
Distinguished Fellow, MedImmune Vaccines
MedImmune, AstraZeneca
Professor Emeritus Stanford University
Robert W. Woodruff Professor in the Department of Microbiology and Immunology
Emory Vaccine Center, Emory University
Barbara Mulach†
Director, Office of Scientific Coordination and Program Operations
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Stanley Plotkin*
Executive Advisor to CEO, Sanofi Pasteur
Emeritus Professor of Pediatrics, University of Pennsylvania
Leighton Read*
General Partner
Alloy Ventures
Robin Robinson†
Director, Biomedical Advanced Research Development Authority
U.S. Department of Health and Human Services
CAPT Rebecca Sheets†
Vaccine Scientific and Regulatory Specialist
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Jeffrey Ulmer
Global Head, External Research
Novartis Vaccines and Diagnostics
Justin Wright
Manager, Bio-Analytical Sciences
BD Medical-Pharmaceutical Systems
THIRD NATIONAL STAKEHOLDER MEETING INFORMED VACCINE DECISION MAKING
Monday, February 2, 2009
Keck Center of the National Academies
500 Fifth Street, N.W.
Washington, DC
Please note:
Panelist titles and affiliations are provided at the end of the agenda.
(*) denotes panelists who will provide brief introductory comments at the beginning of a panel
(†) denotes panelists who contributed to the draft National Vaccine Plan
8:30 am |
Welcome and Overview of the Agenda and the Day’s Proceedings Committee Introductions Claire V. Broome Institute of Medicine (IOM) Committee Chair |
8:45 am |
Panel 1: Who and what informs personal decision making about immunization? Moderator: Edgar Marcuse, IOM committee member |
|
Topics of discussion may include |
|
|
|
Panelists: Louis Z. Cooper (Columbia University) Vicky Debold (National Vaccine Information Center [NVIC]) Julie Downs (Carnegie Mellon) Lynda Flowers (AARP) Samuel L. Katz (Duke University) Julie Leask (University of Sydney) Anita Manning (Freelance Journalist) Mairi Breen Rothman (American College of Nurse-Midwives) Kristine Sheedy†(CDC/NCIRD) |
|
Questions and comments from the audience |
10:30 am |
Break |
10:45 am |
Panel 2: The science of communication and good practices in communicating about vaccines and immunization Moderator: Élaine Chatigny, IOM committee member |
|
Topics of discussion may include |
|
|
|
Panelists: Julie Downs (Carnegie Mellon) Julie Leask* (University of Sydney) Martin G. Myers (NNii) Rebecca Parkin (George Washington University) Kristine Sheedy (CDC/NCIRD) |
|
Questions and comments from the audience |
12:30 pm |
Lunch |
1:30 pm |
Panel 3: Ethical, legal, and policy issues in communicating about immunization Moderator: Sara Rosenbaum, IOM committee member |
|
Topics of discussion may include |
|
|
|
Panelists: Barbara Loe Fisher (NVIC) Ross Silverman (Southern Illinois University) Christina Tan (N.J. Department of Health) L.J. Tan (American Medical Association [AMA]) |
|
Questions and comments from the audience |
3:15 pm |
Break |
3:30 pm |
Panel 4: Communicating to encourage immunization Moderator: Richard Mandsager, IOM committee member |
|
Topics of discussion may include |
|
|
|
Panelists: Louis Z. Cooper (Columbia University) Samuel L. Katz (Duke University) Nancy Lee* (Social Marketing Services, Inc.) Martin G. Myers (NNii) Rebecca Parkin (George Washington University) Glen Nowak (CDC/OEC) Kristine Sheedy* (CDC/NCIRD) Dean Sidelinger* (San Diego County Public Health Services) Christina Tan (N.J. Department of Health) L.J. Tan (AMA) |
5:30 pm |
Adjourn |
PANELIST TITLES AND AFFILIATIONS
Louis Z. Cooper
Professor Emeritus, Pediatrics
College of Physicians and Surgeons
Columbia University
Vicky Debold
Director of Patient Safety
National Vaccine Information Center
Julie Downs
Research Scientist
Department of Social and Decision Sciences
Carnegie Mellon University
Lynda Flowers
Strategic Policy Advisor
AARP Public Policy Institute
Samuel L. Katz
Wilburt C. Davison Professor Emeritus of Pediatrics
Duke University
Julie Leask
Senior Research Fellow
National Centre for Immunisation Research and Surveillance
Conjoint Senior Lecturer
Faculty of Medicine
University of Sydney
Nancy Lee
President
Social Marketing Services, Inc.
Barbara Loe Fisher
President and Co-Founder
National Vaccine Information Center
Anita Manning
Freelance Journalist
Martin G. Myers
Executive Director
National Network for Immunization Information (NNii)
Professor of Pediatrics, Preventive Medicine, and Community Health
Associate Director for Public Health Policy and Education
Sealy Center for Vaccine Development
University of Texas Medical Branch
Glen Nowak
Director
Division of Media Relations
Office of Enterprise Communication
Centers for Disease Control and Prevention
Rebecca Parkin
Associate Dean, Research and Public Health Practice
Professor
Department of Environmental and Occupational Health, and Department of Epidemiology and Biostatistics
School of Public Health and Health Services
George Washington University
Mairi Breen Rothman
Professional Services Consultant
American College of Nurse-Midwives
Kristine Sheedy
Associate Director
Office of Communication Science
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Dean Sidelinger
Deputy Public Health Officer
Public Health Services Administration
San Diego County
Ross Silverman
Chair, Medical Humanities
Professor, Medical Humanities and Psychiatry
School of Medicine
Professor, Medical Jurisprudence
School of Law
Director, Program in Law and Health Policy
Southern Illinois University
Christina Tan
State Epidemiologist
New Jersey Department of Health and Senior Services
L.J. Tan
Director, Medicine and Public Health
American Medical Association
FOURTH NATIONAL STAKEHOLDER MEETING THE SAFETY OF VACCINES AND VACCINATION PRACTICES
Tuesday, April 14, 2009
Keck Center of the National Academies, Room 100
500 Fifth Street, N.W.
Washington, DC
Please note:
Panelist titles and affiliations are provided at the end of the agenda.
8:30 am |
Welcome and Overview of the Agenda and the Day’s Proceedings Committee Introductions Claire V. Broome, Institute of Medicine (IOM) Committee Chair |
8:45 am |
Panel 1: Identifying vaccine safety concerns Moderator: Grace Lee, IOM committee member |
|
Topics of discussion may include
|
|
Participants: Robert Ball, FDA Louis Z. Cooper, Columbia University Adrian Dana, Merck Vicky Debold, NVIC Susan Ellenberg, University of Pennsylvania Neal Halsey, Johns Hopkins University |
|
Florence Houn, Celgene Phillip Krause, FDA Lanie Friedman Ross, University of Chicago Thomas M. Vernon, Sanofi Pasteur Melinda Wharton, CDC/Immunization Safety Office (ISO) |
|
Questions and comments from the audience |
10:30 am |
Break |
10:45 am |
Panel 2: Studying vaccine safety Moderator: Art Reingold, IOM committee member |
|
Topics for discussion may include
|
|
Participants: Robert Ball, FDA Sean Hennessy, University of Pennsylvania John Iskander, CDC/ISO Samuel L. Katz, Duke University Tracy Lieu, Harvard University Andy Pavia, University of Utah, NVAC Vaccine Safety WG Lanie Friedman Ross, University of Chicago |
|
Kenneth J. Rothman, RTI International Patricia Saddier, Merck Brian Strom, University of Pennsylvania Melinda Wharton, CDC/ISO |
|
Questions and comments from the audience |
12:30 pm |
Lunch |
1:30 pm |
Update from the National Vaccine Advisory Committee Safety Working Group Andy Pavia, NVAC working group chair |
1:45 pm |
Panel 3: Basic science (in vivo, in vitro, and human clinical models) Moderator: Claire V. Broom, IOM Committee Chair |
|
Topics for discussion may include
|
|
Participants: George Curlin, NIH/NIAID Kathy Edwards, Vanderbilt University Charles Hackett, NIH/NIAID Neal Halsey, Johns Hopkins University Ruth Karron, Johns Hopkins University Phillip Krause, FDA |
|
Questions and comments from the audience |
3:15 pm |
Break |
3:30 pm |
Panel 4: Policy issues related to vaccine safety and compensation for vaccine injuries Moderator: Sara Rosenbaum, IOM committee member |
|
Topics for discussion may include
|
|
Participants: Louis Z. Cooper, Columbia University Barbara Loe Fisher, NVIC Anthony Robbins, Tufts University Jeff Sconyers, Seattle Children’s Hospital, outgoing chair ACCV Tim Westmoreland, Georgetown University |
|
Questions and comments from the audience |
5:15 pm |
Closing comments |
5:30 pm |
Adjourn |
PANELIST TITLES AND AFFILIATIONS
Robert Ball
Chief, Vaccine Safety Branch
Division of Epidemiology
Food and Drug Administration
George Curlin
Medical Officer
Office of the Director
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Louis Z. Cooper
Professor Emeritus, Pediatrics
College of Physicians and Surgeons
Columbia University
Adrian Dana
Senior Director
Clinical Risk Management and Safety Surveillance
Merck Research Labs
Vicky Debold
Director of Patient Safety
National Vaccine Information Center
Kathryn Edwards
Sarah Sell Professor of Pediatrics
Director, Division of Pediatric Clinical Research
Vanderbilt University School of Medicine
Susan Ellenberg
Professor of Biostatistics
Associate Dean for Clinical Research
University of Pennsylvania School of Medicine
Barbara Loe Fisher
President and Co-founder
National Vaccine Information Center
Charles Hackett
Deputy Director
Division of Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Neal Halsey
Professor
Department of International Health, Disease Prevention & Control
Department of Pediatrics
Johns Hopkins University
Sean Hennessy
Senior Scholar, Epidemiology
Center for Clinical Epidemiology and Biostatistics
Assistant Professor of Epidemiology, University of Pennsylvania School of Medicine
Assistant Professor of Pharmacology, Department of Pharmacology
Director of Ambulatory Drug Use and Effects, University of Pennsylvania Medical Center
Florence Houn
Vice President, Regulatory Affairs
Celgene Corporation
John Iskander
Associate Director for Immunization Safety
Centers for Disease Control and Prevention
Ruth Karron
Director, Center for Immunization Research
Director, Johns Hopkins Vaccine Initiative
Johns Hopkins University
Samuel L. Katz
Wilburt C. Davison Professor Emeritus of Pediatrics
Duke University
Phillip Krause
Laboratory Chief
Lead Research Investigator
Center for Biologics Evaluation and Research
Food and Drug Administration
Tracy Lieu
Professor
Director of Faculty Development
Director, Center for Child Health Care Studies
Department of Ambulatory Care and Prevention
Harvard Pilgrim Health Care and Harvard Medical School
Andy Pavia
Professor, Division of Infectious Diseases
University of Utah School of Medicine
Chair, Vaccine Safety Working Group, National Vaccine Advisory Committee
Anthony Robbins
Professor
Department of Public Health and Family Medicine
Tufts University
Lanie Friedman Ross
Carolyn and Matthew Bucksbaum Professor of Clinical Ethics
Professor, Departments of Pediatrics, Medicine, and Surgery
Associate Director, MacLean Center for Clinical Medical Ethics
University of Chicago
Kenneth J. Rothman
Distinguished Fellow in Epidemiology
Vice President, Epidemiology Research
RTI International
Patricia Saddier
Senior Director, Epidemiology Department
Merck Research Laboratories
Jeff Sconyers
Senior Vice President and General Counsel
Seattle Children’s Hospital
Chair, Advisory Commission on Childhood Vaccines
Brian Strom
George S. Pepper Professor of Public Health and Preventive Medicine
Departments of Biostatistics and Epidemiology
University of Pennsylvania
Thomas M. Vernon
Consultant with Sanofi Pasteur
Former VP, Merck Vaccine Division
Former Executive Director, Colorado Department of Health
Tim Westmoreland
Visiting Professor of Law
Georgetown University
Melinda Wharton
Deputy Director
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
Some federal agencies contributed to the development of the draft strategic National Vaccine Plan
FIFTH NATIONAL STAKEHOLDER MEETING VACCINES AND GLOBAL HEALH
Thursday, June 4, 2009
The Seattle Public Library
1000 Fourth Avenue
Seattle, Washington
Please note:
Complete participant affiliations are provided at the end of the agenda.
8:30 am |
Welcome, Overview, and Committee Introductions Claire V. Broome, IOM Committee Chair |
8:45 am |
Panel 1: Development of new vaccines and those needed for global use Moderator: Claire Broome, IOM Committee Chair |
|
Topics of discussion may include
|
|
Discussants: Norman Baylor, CBER/FDA (by phone) Brent Burkholder, NCIRD/CDC Thomas Cherian, World Health Organization (WHO) Mark Feinberg, Merck John Ferguson, Novartis Vaccines & Diagnostics Orin Levine, Johns Hopkins University Adel Mahmoud, Princeton University (by phone) Margaret McCluskey, U.S. Agency for International Development (USAID) Regina Rabinovich, Gates Foundation Jerald Sadoff, Aeras Global TB Vaccine Foundation Theodore Tsai, Novartis Justin Wright, BD Medical-Pharmaceutical Systems |
10:30 am |
Break |
10:45 am |
Panel 2: Immunization program issues: Infrastructure, communication, impact of eradication or elimination Moderator: Milagritos Tapia, IOM committee member |
|
Topics of discussion may include
|
|
Discussants: Brent Burkholder, NCIRD/CDC Thomas Cherian, WHO Rod Hausser, BD Medical-Pharmaceutical Systems |
|
Orin Levine, Johns Hopkins University Margaret McCluskey, USAID Robert Steinglass, John Snow Inc. Linda Venczel, Gates Foundation |
12:30 pm |
Lunch |
1:30 pm |
Panel 3: Surveillance of safety, effectiveness, coverage, disease Moderator: Art Reingold, IOM committee member |
|
Topics of discussion may include
|
|
Discussants: Brent Burkholder, NCIRD/CDC John Ferguson, Novartis Vaccines & Diagnostics David Fleming, Director & Health Officer, WA Kathy Neuzil, Program for Appropriate Technology in Health (PATH) Robert Steinglass, John Snow Inc. Linda Venczel, Gates Foundation |
3:15 pm |
Break |
3:30 pm |
Panel 4: Financing vaccine development and purchase Moderator: David Paltiel, IOM committee member |
|
Topics of discussion may include
|
|
|
|
Discussants: Brent Burkholder, NCIRD/CDC Orin Levine, Johns Hopkins University Melinda F. Moree, Global Health Services Regina Rabinovich, Gates Foundation Jerald Sadoff, Aeras Global TB Vaccine Foundation |
5:30 pm |
Adjourn |
PANELIST TITLES AND AFFILIATIONS
Jon Kim Andrus
Professor, Department of Global Health Director, Global Health MPH Program
George Washington University
Norman Baylor
Director, Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
Food and Drug Administration
Brent Burkholder
Director, Global Immunization Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Thomas Cherian
Coordinator
Expanded Programme on Immunization
Department of Immunization, Vaccines and Biologicals
World Health Organization
Mark Feinberg
Vice President, Medical Affairs and Policy
Merck Vaccines and Infectious Diseases
Merck & Co., Inc.
John Ferguson
Vice President and Global Head
Pharmacovigilance & Medical Safety
Novartis Vaccines & Diagnostics
David Fleming
Director and Health Officer
Department of Public Health
Seattle/King County
Rod Hausser
Director
Business Development and Operations
BD Medical-Pharmaceutical Systems
Orin Levine
Executive Director, PneumoADIP
Associate Professor, International Health
Johns Hopkins University
Adel Mahmoud
Woodrow Wilson School of Public and International Affairs
Department of Molecular Biology
Princeton University
Margaret McCluskey
Senior Technical Advisor, HIV Vaccines
GH/Office of HIV & AIDS
U.S. Agency for International Development
Melinda F. Moree
Vice President, Global Health Services
Kathy Neuzil
Director, Influenza Vaccine Project
Clinical Director, Rotavirus Vaccine Program
PATH
Regina Rabinovich
Director, Infectious Diseases Development
Global Health Program
The Bill & Melinda Gates Foundation
Jerald Sadoff
President and Chief Executive Officer
Aeras Global TB Vaccine Foundation
Robert Steinglass
Technical Director, IMMUNIZATIONBasics Project
John Snow Inc.
Theodore Tsai
Senior Vice President, Scientific Affairs
Novartis
Linda Venczel
Vaccine-Preventable Diseases
Integrated Health Systems Development
The Bill & Melinda Gates Foundation
Justin Wright
Manager, Bio-Analytical Sciences
BD Medical-Pharmaceutical Systems